World's Best Scientists 2026 revealed!
Award Badge
Best Female Scientists
2025

D-Index & Metrics

Best Female Scientists

D-Index
118
Citations
56022
World Ranking
611
National Ranking
373

Immunology

D-Index
119
Citations
59924
World Ranking
339
National Ranking
214

Medicine

D-Index
120
Citations
60165
World Ranking
3715
National Ranking
2046

Judy Lieberman publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Judy Lieberman sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 316 publications — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Judy Lieberman D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Judy Lieberman sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 119 D-Index — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2025 - Research.com Best Female Scientists Award
  • 2020 - Member of the National Academy of Sciences
  • 2018 - Fellow of the American Association for the Advancement of Science (AAAS)
  • 2008 - Fellow of the American Academy of Arts and Sciences

Overview

Judy Lieberman is affiliated with Boston Children's Hospital in the United States. Their research focuses on molecular biology, immunology, infectious diseases, neurology, and public health. The main fields of study include biochemistry, genetics and molecular biology, medicine, and immunology and microbiology.

Their work covers several prominent topics, such as:

  • Inflammasome and immune disorders
  • Interferon and immune responses
  • Immune cell function and interaction
  • Heme oxygenase-1 and carbon monoxide
  • COVID-19 clinical research studies
  • SARS-CoV-2 and COVID-19 research
  • Immune response and inflammation

Recent influential papers authored or coauthored by Lieberman include:

  • "Gasdermin E suppresses tumour growth by activating anti-tumour immunity," 2020, published in Nature
  • "FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation," 2020, published in Nature Immunology
  • "Channelling inflammation: gasdermins in physiology and disease," 2021, published in Nature Reviews Drug Discovery
  • "FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation," 2022, published in Nature
  • "Gasdermin D pore structure reveals preferential release of mature interleukin-1," 2021, published in Nature

Frequent coauthors include:

  • Hao Wu
  • Zhibin Zhang
  • Xing Liu
  • Caroline Junqueira
  • Ying Zhang

Their work has been published in multiple venues with notable frequency, including:

  • Nature
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Proceedings of the National Academy of Sciences
  • Science Immunology
  • Cancer Immunology Research

Judy Lieberman has been recognized with several awards, including:

  • Member of the National Academy of Sciences (2020)
  • Fellow of the American Association for the Advancement of Science (AAAS) (2018)
  • Fellow of the American Academy of Arts and Sciences (2008)

Best Publications

  • Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores

    Xing Liu;Zhibin Zhang;Zhibin Zhang;Jianbin Ruan;Jianbin Ruan;Youdong Pan

  • let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells

    Fengyan Yu;Fengyan Yu;Herui Yao;Pengcheng Zhu;Xiaoqin Zhang

  • Identification of Host Proteins Required for HIV Infection Through a Functional Genomic Screen

    Abraham L. Brass;Derek M. Dykxhoorn;Yair Benita;Nan Yan

  • RNA interference targeting Fas protects mice from fulminant hepatitis

    Erwei Song;Sang-Kyung Lee;Jie Wang;Nedim Ince

  • Gasdermin E suppresses tumour growth by activating anti-tumour immunity.

    Zhibin Zhang;Zhibin Zhang;Ying Zhang;Ying Zhang;Shiyu Xia;Shiyu Xia;Qing Kong

  • Interfering with disease: a progress report on siRNA-based therapeutics.

    Antonin de Fougerolles;Hans Peter Vornlocher;John Maraganore;Judy Lieberman

  • Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors

    Erwei Song;Pengcheng Zhu;Sang Kyung Lee;Dipanjan Chowdhury

  • siRNA-directed inhibition of HIV-1 infection.

    Carl D. Novina;Michael F. Murray;Derek M. Dykxhoorn;Paul J. Beresford

  • Coding-Independent Regulation of the Tumor Suppressor PTEN by Competing Endogenous mRNAs

    Yvonne Tay;Lev Kats;Leonardo Salmena;Dror Weiss

  • The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal

    Judy Lieberman

  • FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation

    Jun Jacob Hu;Jun Jacob Hu;Xing Liu;Xing Liu;Xing Liu;Shiyu Xia;Shiyu Xia;Zhibin Zhang;Zhibin Zhang

  • Knocking down disease: a progress report on siRNA therapeutics.

    Anders Wittrup;Judy Lieberman

  • Death by a thousand cuts: granzyme pathways of programmed cell death.

    Dipanjan Chowdhury;Judy Lieberman

  • FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation

    Unknown

  • Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus.

    Min Ae Lee-Kirsch;Maolian Gong;Dipanjan Chowdhury;Lydia Senenko

  • γ-H2AX Dephosphorylation by Protein Phosphatase 2A Facilitates DNA Double-Strand Break Repair

    Dipanjan Chowdhury;Michael-Christopher Keogh;Haruhiko Ishii;Craig L. Peterson

  • Channelling inflammation: gasdermins in physiology and disease.

    Xing Liu;Shiyu Xia;Shiyu Xia;Zhibin Zhang;Zhibin Zhang;Hao Wu;Hao Wu

  • miR-24 Inhibits Cell Proliferation by Targeting E2F2, MYC, and Other Cell-Cycle Genes via Binding to “Seedless” 3′UTR MicroRNA Recognition Elements

    Ashish Lal;Francisco Navarro;Christopher A. Maher;Laura E. Maliszewski

  • Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor.

    Zusen Fan;Paul J. Beresford;David Y. Oh;Dong Zhang

  • Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown

    Anders Wittrup;Angela Ai;Xing Liu;Peter Hamar

  • Desperately seeking microRNA targets.

    Marshall Thomas;Judy Lieberman;Ashish Lal;Ashish Lal

  • A phosphatase complex that dephosphorylates γH2AX regulates DNA damage checkpoint recovery

    Michael Christopher Keogh;Jung Ae Kim;Michael Downey;Jeffrey Fillingham

  • The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1

    Nan Yan;Ashton D Regalado-Magdos;Bart Stiggelbout;Min Ae Lee-Kirsch

Frequent Co-Authors

Hao Wu
Hao Wu Harvard University
Ashish Lal
Ashish Lal National Institutes of Health
Dipanjan Chowdhury
Dipanjan Chowdhury Harvard University
Erwei Song
Erwei Song Sun Yat-sen University
Tomas Kirchhausen
Tomas Kirchhausen Boston Children's Hospital
Ricardo T. Gazzinelli
Ricardo T. Gazzinelli Universidade Federal de Minas Gerais
Winston Hide
Winston Hide Harvard Medical School
Akiko Hata
Akiko Hata University of California, San Francisco
Bruce D. Walker
Bruce D. Walker Harvard University
Bing Lim
Bing Lim Thymmune Therapeutics

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry opens the door to a wide variety of dynamic and in-demand career options. For those interested in pharmacy, pursuing pharmd online programs is an excellent path to advanced roles in pharmaceutical sciences or clinical practice.

If your interests lean toward the science of movement, health, or sports, an exercise science and nutrition degree online provides foundational knowledge for careers in wellness, fitness, or rehabilitation. Similarly, earning a kinesiology degree online is ideal for students aiming to work in physical therapy, sports medicine, or research.

There’s also a growing need for mental health professionals who understand biochemistry and physiology. For those with a healthcare background, the shortest pmhnp certificate program can provide a fast track into psychiatric and mental health nurse practitioner roles.

By combining online learning with Biology or Biochemistry, students can gain flexible access to specialized fields, keep up with industry trends, and expand their career opportunities across healthcare and beyond.

Best Scientists Citing Judy Lieberman

Trending Scientists

Recently Published Articles